AllPeptides.eu - Advanced Peptide Research
    Single Peptides
    Cognitive

    Semax (10mg)

    Intranasal or subcutaneous1–2x daily10mg

    Reviewed by the AllPeptides.eu Editorial Team·Last reviewed: 2026-06-16

    🇷🇺 МЗ РФ

    Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.

    Approved by select regulatory agencies — not FDA/EMA
    Educational information. Not medical advice or a recommendation for use.

    ⚠️ For informational/educational purposes only. Not medical advice. We do not sell any products. Self-treatment carries serious risks — consult a healthcare professional. Disclaimer

    Available sizes:
    10mg
    Nasal Spray
    5mg

    Research monograph

    See the full Semax encyclopedia page with mechanism, evidence tier, related variants and research context.

    Open monograph
    Free Access

    How It Works

    Semax increases BDNF, regulates dopamine/serotonin, improves cerebral blood flow, and protects neurons from oxidative damage.

    Quick Start

    • Typical dose: 200–600mcg intranasally or subcutaneously
    • Frequency: 1–2x/day
    • Storage: 2–8°C after reconstitution
    Detailed Protocol Data

    Dosing Table — Semax 10mg

    Educational only
    Vial Size— affects syringe units
    BAC Water2 mL
    Concentration5.00 mg/mL

    Route: Intranasal or subcutaneous | Frequency: 1–2x daily

    WeekDoseUnits (per injection)
    1–2
    100–200mcg
    2–4 Units (0.02–0.04 mL)
    3–4
    200–400mcg
    4–8 Units (0.04–0.08 mL)
    5+
    400–600mcg
    8–12 Units (0.08–0.12 mL)

    Studies report administration morning/midday. Cycle for 2–4 weeks. The 10mg vial provides for a longer cycle duration.

    Related compounds

    Reconstitution Steps

    1. Clean the stoppers with an alcohol wipe.
    2. Draw up 2mL of bacteriostatic water.
    3. Slowly inject against the side wall of the vial.
    4. Gently swirl until fully dissolved.
    5. Store in the refrigerator (2–8°C).

    Protocol Overview

    • Semax is a Russian-developed nootropic based on a fragment of ACTH.
    • It significantly increases BDNF without hormonal activity.
    • Clinically approved in Russia for stroke and cognitive disorders.

    Dosing Protocol

    • Start with 100–200mcg, 1x/day.
    • Increase to 400–600mcg, 1–2x/day.
    • Cycle: 2–4 weeks on, 1–2 weeks off.
    • Combining with Selank enhances anxiolytic/nootropic effects.
    • Break between cycles: After the cycle, a 2–4 week break is recommended. The break prevents tolerance to BDNF.

    Washout & Cycle Restart

    When can I restart?

    After the cycle, a 2–4 week break is recommended. The break prevents tolerance to BDNF.

    Minimum wait period: 2 weeks

    Storage Instructions

    • Reconstituted: 2–8°C, use within 30 days.
    • Powder: -20°C or 2–8°C.

    Important Notes

    • Intranasal administration provides faster absorption.
    • Does not affect the HPA axis — safe for long-term use.
    • Does not cause dependence or tolerance.
    Clinical Analysis & Safety

    Potential Benefits & Side Effects

    Potential Benefits:

    • Improved memory and learning
    • Enhanced concentration
    • Neuroprotection (increased BDNF)
    • Anxiolytic effect without sedation
    • Improved cerebral circulation

    Potential Side Effects:

    • Mild headache (rare)
    • Nasal dryness (intranasal)
    • Rare: insomnia if taken late

    ⚠️ Serious Warnings & Long-Term Risks

    The following warnings are based on published literature, FDA labels, and post-marketing surveillance. They do not constitute medical advice. Consult a healthcare professional.

    🧠 Neurological
    🟡 Moderate / Theoretical

    Neurotrophic action — uncertain long-term effects

    Semax increases BDNF, NGF, and modifies dopaminergic/serotonergic signaling. Long-term use may theoretically alter neuroplasticity. No studies >6 months in humans.

    📄 Neurosci Lett 2006

    References

    1. Semax Neuroprotection — Levitskaya NG, et al. Neuroprotective effects of Semax in conditions of MPTP-induced neurodegeneration. Neurosci Behav Physiol. 2004;34(4):399-405.
      View Source
    2. Semax & Neurotrophin Gene Activation — Dmitrieva VG, et al. Semax and Pro-Gly-Pro activate the transcription of neurotrophins after cerebral ischemia. Cell Mol Neurobiol. 2010;30(1):71-79.
      View Source

    Recommended Supplements

    Research Sources & Verified Data
    …
    Clinical Trials
    …
    PubMed Studies
    Research-only
    FDA Status
    1
    Regulatory Approvals
    Verified across ClinicalTrials.gov, PubMed & FDA

    External Sources & Regulatory Status

    Regulatory Approvals

    🇷🇺
    МЗ РФ
    Approved

    Stroke / Cognitive enhancement (2001)

    Approved in Russia (2001)

    No official regulatory source available yet — research peptide.

    Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.

    Summary:
    1 Approvals
    0 PubMed
    0 Clinical Studies

    Continue Your Research

    Explore tools and guides related to this protocol.

    Educational contentRegularly reviewed & maintainedEvidence-based review

    Important Disclaimer

    The content of this website is provided exclusively for informational and educational purposes within the context of research literature.

    Read the full Disclaimer →

    Educational Navigator

    Educational reading navigator

    Find where to start in research peptide science through evidence, safety context and regulatory awareness.

    Covers

    Evidence levelsSafety contextRegulatory overviewLiterature readingResearch methodEducational reports
    5 min readEvidence-firstOpen access
    Open evidence framework

    New knowledge, new tools and selected updates from AllPeptides.eu